Conley, Pamela B.
Portola Pharmaceuticals (United States)
2 papers on CoChatORCID 0000-0001-9400-6531
Most cited papers
- Verified
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Siegal, D. M., Curnutte, J. T., Connolly, S. J., Lu, G., Conley, P. B., Wiens, B. L., Mathur, V. S., Castillo, J., Bronson, M. D., Leeds, J. M., et al. (2015) · New England Journal of Medicine
Atrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis Mechanisms
Cited by 1,047
- Verified
Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment
Guo, A., Lu, P., Coffey, G., Conley, P., Pandey, A., & Wang, Y. L. (2017) · Oncotarget
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 52
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free